Private Management Group Inc. Trims Johnson & Johnson Holdings

Hedge fund reduces stake in pharmaceutical giant by nearly 25% in Q3

Mar. 14, 2026 at 9:21am

Got story updates? Submit your updates here. ›

Private Management Group Inc. has reduced its position in Johnson & Johnson (NYSE:JNJ) by 24.9% during the third quarter, according to a recent SEC filing. The firm sold 44,655 shares, leaving it with 134,750 shares of the healthcare company's stock valued at $24,985,000 at the end of the reporting period.

Why it matters

This filing provides insight into the investment decisions of Private Management Group, a prominent hedge fund. Changes in major institutional holdings of blue-chip stocks like Johnson & Johnson can signal broader market trends and investor sentiment.

The details

Private Management Group sold a significant portion of its Johnson & Johnson stake, reducing its overall position by nearly 25%. The firm cited unspecified factors that led to this portfolio adjustment during the third quarter.

  • The filing covers the third quarter of 2026.

The players

Private Management Group Inc.

A hedge fund that manages investments and has previously held a sizable position in Johnson & Johnson stock.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

This move by Private Management Group reflects broader shifts in the investment landscape, as institutional investors reevaluate their positions in major pharmaceutical companies like Johnson & Johnson. The filing provides a glimpse into the decision-making process of a prominent hedge fund, which could signal changing market dynamics and investor sentiment.